The objectives of this manuscript are to describe a case report of a patient whose phenelzine maintenance therapy was discontinued due to concern for a phenelzine-morphine drug interaction, to review the available literature regarding the potential for this drug-drug interaction, and provide recommendations for this clinical scenario. A PubMed/MEDLINE literature search was conducted and all publications determined to be relevant to this case report were included. Literature describing in vitro data, case reports/human studies, and review articles concerning the interaction between morphine and monoamine oxidase inhibitors (MAOIs) were included. A total of 14 publications pertinent to the potential phenelzine-morphine interaction were included in this review including 5 in vitro studies, 4 human studies, and 6 review articles detailing the drug interaction profile between opioids and antidepressants. Of these publications, only a single case report of a potential drug interaction between morphine and phenelzine was identified. The literature suggesting a drug interaction between morphine and phenelzine is limited. The combination of phenelzine and morphine, with close monitoring for signs and symptoms of serotonin syndrome, is reasonable for patients with appropriate indications for both agents.
BakerGBCouttsRTMcKennaKF, et al.Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review. J Psychiatr Neurosci. 1992;17(5):206–214. https://www.ncbi.nlm.nih.gov/pubmed/1362653
ShulmanKIFischerHDHerrmannN, et al.Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults. J Clin Psychiatry. 2009;70(12):1681–1686. https://www.ncbi.nlm.nih.gov/pubmed/19852903
CoddEEShankRPSchupskyJJ, et al.Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. J Pharmacol Exp Ther. 1995;274(3):1263–1270. https://www.ncbi.nlm.nih.gov/pubmed/7562497
Lexicomp Online [Internet]. Lexi-Comp, Inc. c1978-2015. Accessed January 1, 2019. http://online.lexi.com
14.
Beaudoin-GobertMSgambato-FaureV. Serotonergic pharmacology in animal models: from behavioral disorders to dyskinesia. Neuropharmacol. 2014;81:15–30. https://www.ncbi.nlm.nih.gov/pubmed/24486710
WittmannMSchaafTPetersI, et al.The effects of fentanyl-like opioids and hydromorphone on human 5-HT3A receptors. Anesth Analg. 2008;107(1):107–112. https://pubmed.ncbi.nlm.nih.gov/18635474/
17.
Baptista-HonDTDeebTZOthmanNA, et al.The 5HT-3B subunit affects high-potency inhibition of 5-HT3 receptors by morphine. Br J Pharmacol. 2012;165(3):693–704. https://www.ncbi.nlm.nih.gov/pubmed/21740409
18.
BarannMStamerUMLyutenskaM, et al.Effects of opioids on human serotonin transporters. Naunyn-Schmiedebergs Arch Pharmacol. 2015;388(1):43–49. https://www.ncbi.nlm.nih.gov/pubmed/25332055
19.
RickliALiakoniEHoenerMC, et al.Opioid-induced inhibition of the human 5-HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome. Br J Pharmacol. 2018;175(3):532–543. https://www.ncbi.nlm.nih.gov/pubmed/29210063
20.
Mateo-CarrascoHMuñoz-AguileraEMGarcía-TorrecillasJM, et al.Serotonin syndrome probably triggered by a morphine-phenelzine interaction. Pharmacotherapy. 2015;35(6):e102–105. https://www.ncbi.nlm.nih.gov/pubmed/25903219
21.
el-GanzouriARIvankovichADBravermanB, et al.Monoamine oxidase inhibitors: should they be discontinued preoperatively?Anesth Analg. 1985;64(6):592–596. https://www.ncbi.nlm.nih.gov/pubmed/4003777
22.
Evans-ProsserCD.The use of pethidine and morphine in the presence of monoamine oxidase inhibitors. Br J Anaesth. 1968;40(4):279–282. https://www.ncbi.nlm.nih.gov/pubmed/5654977
23.
RastogiRSwarmRAPatelTA. Case scenario: opioid association with serotonin syndrome: implications to the practitioners. Anesthesiol. 2011;115(6):1291–1298. https://www.ncbi.nlm.nih.gov/pubmed/22037635
BaldoBA. Opioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects. Arch Toxicol. 2018;92(8):2457–2473. https://www.ncbi.nlm.nih.gov/pubmed/29916050
28.
BrowneBLinterS. Monoamine oxidase inhibitors and narcotic analgesics. A critical review of the implications for treatment. Br J Psychiatry. 1987;151:210–212. https://www.ncbi.nlm.nih.gov/pubmed/2891392
29.
BaldoBARoseMA. The anaesthetist, opioid analgesic drugs, and serotonin toxicity: a mechanistic and clinical review. Br J Anaesth. 2020;124(1):44–62. https://pubmed.ncbi.nlm.nih.gov/31653394/
